Department of Medicine at The Icahn School of Medicine at Mount Sinai/James J. Peters VAMC, United States.
Dr. Weiping Qin, MD, Ph.D., is a seasoned researcher with extensive experience in molecular biology and spinal cord injury research. Currently serving as a Research Health Science Specialist at the James J. Peters VA Medical Center and a Professor of Medicine at the Icahn School of Medicine at Mount Sinai, Dr. Qin has contributed significantly to the fields of neurology, osteoporosis, and molecular endocrinology. With over 15 years of experience in the VA system, his work is recognized through patents, impactful publications, and professional affiliations.
Profile
Scopus
Google Scholar
Dr. Qin earned his MD from Fujian Medical University, China, and his PhD in Molecular Biology from Kanazawa University School of Medicine, Japan, under the mentorship of Dr. Seishi Murakami. His postdoctoral training in Psychiatry at Icahn School of Medicine, guided by Dr. Giulio M. Pasinetti, sharpened his focus on neurological mechanisms in chronic illnesses. This solid foundation paved the way for a career dedicated to bridging the gap between molecular research and clinical application. 🎓🔬🧬
Work Experience 💼:
Dr. Qin has held pivotal roles in academia and research. At James J. Peters VA Medical Center, he progressed from Research Health Science Specialist (Grade 13) to Grade 14, contributing to spinal cord injury and neuromuscular health advancements. Concurrently, he served as a faculty member at Mount Sinai, ascending from Assistant to full Professor. Dr. Qin’s global experience includes tenures in China, Japan, and the U.S., where he has driven interdisciplinary collaborations and secured federal research funding. His service also includes membership in VA and NIH review panels, shaping policies and evaluations. 🌍🛠️💡
Awards and Honors 🏆
Dr. Qin’s work has garnered recognition from prominent organizations, including the Military Health System Research Symposium Poster Award and the Sasagawa Medical Research Award. Media outlets like Reuters and The Wall Street Journal have covered his breakthroughs in bone disease treatment. Additionally, his research has been highlighted by the Department of Defense and NIH. These accolades underscore his innovative contributions to molecular and translational medicine. 🏅📰🎖️
Research Interests:
Dr. Qin’s research focuses on the cellular and molecular mechanisms underlying spinal cord injuries and associated neuromuscular disorders. His innovative work aims to develop pharmacological interventions targeting osteoporosis, bone regeneration, and neuroinflammation. Leveraging advanced molecular biology tools, he bridges experimental findings with clinical applications, significantly impacting rehabilitation medicine and patient care. 🔬🦴🧠
📚 Publications
Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease
Authors: L Ho, W Qin, PN Pompl, Z Xiang, J Wang, Z Zhao, Y Peng, G Cambareri, …
Citations: 775
Year: 2004
Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction
Authors: W Qin, T Yang, L Ho, Z Zhao, J Wang, L Chen, W Zhao, M Thiyagarajan, …
Citations: 759
Year: 2006
PGC-1α expression decreases in the Alzheimer disease brain as a function of dementia
Authors: W Qin, V Haroutunian, P Katsel, CP Cardozo, L Ho, JD Buxbaum, …
Citations: 439
Year: 2009
Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer’s disease
Authors: J Wang, L Ho, W Qin, AB Rocher, I Seror, N Humala, K Maniar, G Dolios, …
Citations: 368
Year: 2005
RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region
Authors: T Yamashita, S Kaneko, Y Shirota, W Qin, T Nomura, K Kobayashi, …
Citations: 334
Year: 1998
Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity
Authors: Y Shirota, H Luo, W Qin, S Kaneko, T Yamashita, K Kobayashi, …
Citations: 325
Year: 2002
Myostatin inhibits osteoblastic differentiation by suppressing osteocyte-derived exosomal microRNA-218: A novel mechanism in muscle-bone communication
Authors: Y Qin, Y Peng, W Zhao, J Pan, H Ksiezak-Reding, C Cardozo, Y Wu, …
Citations: 276
Year: 2017
Bone and muscle loss after spinal cord injury: organ interactions
Authors: W Qin, WA Bauman, C Cardozo
Citations: 224
Year: 2010
Calorie restriction attenuates Alzheimer’s disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus)
Authors: W Qin, M Chachich, M Lane, G Roth, M Bryant, R De Cabo, MA Ottinger, …
Citations: 222
Year: 2006
A therapeutic role for cyclooxygenase‐2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis
Authors: PN Pompl, L Ho, M Bianchi, T McManus, W Qin, GM Pasinetti
Citations: 178
Year: 2003
Conclusion
Dr. Weiping Qin exemplifies excellence in research, innovation, and service, making him a strong candidate for the Best Researcher Award. His groundbreaking work in spinal cord injury and molecular biology, coupled with his dedication to the VA system, positions him as a leader in his field. Addressing areas for improvement, such as collaboration and grant acquisition, could further enhance his impact. Nevertheless, his contributions already stand out as transformative and worthy of recognition.